The 1 analysts offering 12-month price forecasts for Eloxx Pharmaceuticals Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +1,150.00% increase from the last price of 4.80.
The current consensus among 1 polled investment analysts is to Buy stock in Eloxx Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.50
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.